Arginyl glutamine dipeptide - Infant Bacterial Therapeutics
Alternative Names: Arginyl-glutamine dipeptide - Infant Bacterial Therapeutics; IBP 1118Latest Information Update: 14 Nov 2022
At a glance
- Originator Infant Bacterial Therapeutics
- Class Dipeptides; Eye disorder therapies
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Retinopathy of prematurity